Dosch J - Search Results

1

Modeling selective elimination of quiescent cancer cells from bone marrow.

Cavnar SP, Rickelmann AD, Meguiar KF, Xiao A, Dosch J, Leung BM, Cai Lesher-Perez S, Chitta S, Luker KE, Takayama S, Luker GD. Cavnar SP, et al. Among authors: dosch j. Neoplasia. 2015 Aug;17(8):625-33. doi: 10.1016/j.neo.2015.08.001. Neoplasia. 2015. PMID: 26408255 Free PMC article.

2

Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells.

Stacer AC, Wang H, Fenner J, Dosch JS, Salomonnson A, Luker KE, Luker GD, Rehemtulla A, Ross BD. Stacer AC, et al. Among authors: dosch js. Mol Imaging. 2015;14:414-28. Mol Imaging. 2015. PMID: 26431589 Free PMC article.

3

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency.

Dosch J, Ziemke E, Wan S, Luker K, Welling T, Hardiman K, Fearon E, Thomas S, Flynn M, Rios-Doria J, Hollingsworth R, Herbst R, Hurt E, Sebolt-Leopold J. Dosch J, et al. Oncotarget. 2017 May 10;8(39):65090-65099. doi: 10.18632/oncotarget.17780. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029414 Free PMC article.

4

Pancreatic cancer stem cells.

Lee CJ, Dosch J, Simeone DM. Lee CJ, et al. Among authors: dosch j. J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702. J Clin Oncol. 2008. PMID: 18539958 Review.

5

c-Met is a marker of pancreatic cancer stem cells and therapeutic target.

Li C, Wu JJ, Hynes M, Dosch J, Sarkar B, Welling TH, Pasca di Magliano M, Simeone DM. Li C, et al. Among authors: dosch j. Gastroenterology. 2011 Dec;141(6):2218-2227.e5. doi: 10.1053/j.gastro.2011.08.009. Epub 2011 Aug 22. Gastroenterology. 2011. PMID: 21864475

6

Cancer stem cells: a new theory regarding a timeless disease.

Sarkar B, Dosch J, Simeone DM. Sarkar B, et al. Among authors: dosch j. Chem Rev. 2009 Jul;109(7):3200-8. doi: 10.1021/cr9000397. Chem Rev. 2009. PMID: 19522504 Review. No abstract available.

7

Cancer stem cell marker phenotypes are reversible and functionally homogeneous in a preclinical model of pancreatic cancer.

Dosch JS, Ziemke EK, Shettigar A, Rehemtulla A, Sebolt-Leopold JS. Dosch JS, et al. Cancer Res. 2015 Nov 1;75(21):4582-92. doi: 10.1158/0008-5472.CAN-14-2793. Epub 2015 Sep 10. Cancer Res. 2015. PMID: 26359451 Free PMC article.

8

Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6.

Ziemke EK, Dosch JS, Maust JD, Shettigar A, Sen A, Welling TH, Hardiman KM, Sebolt-Leopold JS. Ziemke EK, et al. Clin Cancer Res. 2016 Jan 15;22(2):405-14. doi: 10.1158/1078-0432.CCR-15-0829. Epub 2015 Sep 14. Clin Cancer Res. 2016. PMID: 26369631 Free PMC article.

9

Pancreatic cancer and hedgehog pathway signaling: new insights.

Dosch JS, Pasca di Magliano M, Simeone DM. Dosch JS, et al. Pancreatology. 2010;10(2-3):151-7. doi: 10.1159/000225923. Epub 2010 May 7. Pancreatology. 2010. PMID: 20453550 Free PMC article.

10

The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.

Nyati S, Schinske-Sebolt K, Pitchiaya S, Chekhovskiy K, Chator A, Chaudhry N, Dosch J, Van Dort ME, Varambally S, Kumar-Sinha C, Nyati MK, Ray D, Walter NG, Yu H, Ross BD, Rehemtulla A. Nyati S, et al. Among authors: dosch j. Sci Signal. 2015 Jan 6;8(358):ra1. doi: 10.1126/scisignal.2005379. Sci Signal. 2015. PMID: 25564677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page